Blocking of programmed cell death-ligand 1 (PD-L1) expressed on endothelial cells promoted the recruitment of CD8^+IFN-γ^+ T cells in atherosclerosis

[1]  P. Libby.  The changing landscape of atherosclerosis , 2021, Nature.

[2]  L. Rosenberg,et al.  Islet neogenesis associated protein (INGAP) protects pancreatic β cells from IL-1β and IFNγ-induced apoptosis , 2021, Cell death discovery.

[3]  Chinmoy Ghosh,et al.  A snapshot of the PD-1/PD-L1 pathway , 2021, Journal of Cancer.

[4]  N. Mehta,et al.  T Cells in Autoimmunity-Associated Cardiovascular Diseases , 2020, Frontiers in Immunology.

[5]  Nicholas J Chandler,et al.  T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors , 2020, International journal of molecular sciences.

[6]  Xiaofeng Yang,et al.  Vascular Endothelial Cells and Innate Immunity. , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[7]  Yuan Gao,et al.  anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells , 2020, Cell Death & Disease.

[8]  A. Orekhov,et al.  Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque , 2020, International journal of molecular sciences.

[9]  K. Ley,et al.  T cell subsets and functions in atherosclerosis , 2020, Nature Reviews Cardiology.

[10]  Haidong Dong,et al.  Bidirectional signals of PD-L1 in T cells that fraternize with cancer cells , 2020, Nature Immunology.

[11]  S. Meierjohann,et al.  IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression , 2019, Journal of Experimental & Clinical Cancer Research.

[12]  T. Ishiko,et al.  PD‐L1 expression enhancement by infiltrating macrophage‐derived tumor necrosis factor‐α leads to poor pancreatic cancer prognosis , 2018, Cancer science.

[13]  M. Raza,et al.  Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases , 2018, Biomolecular concepts.

[14]  T. Schumacher,et al.  Regulation and Function of the PD-L1 Checkpoint. , 2018, Immunity.

[15]  J. Lang,et al.  Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer. , 2017, Oncotarget.

[16]  Qiuyang Zhang,et al.  Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells. , 2017, Immunology letters.

[17]  Ronald D. Vale,et al.  T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition , 2016, Science.

[18]  M. Kurrer,et al.  Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice , 2012, The Journal of experimental medicine.

[19]  J. Darnell,et al.  The JAK-STAT pathway at twenty. , 2012, Immunity.

[20]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[21]  A. Dietz,et al.  Soluble B7-H1: differences in production between dendritic cells and T cells. , 2012, Immunology letters.

[22]  A. Sharpe,et al.  Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. , 2007, The Journal of clinical investigation.

[23]  H. Nie,et al.  Aberrant Regulation of Synovial T Cell Activation by Soluble Costimulatory Molecules in Rheumatoid Arthritis1 , 2006, The Journal of Immunology.

[24]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[25]  M. Isobe,et al.  Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[26]  G. Freeman,et al.  Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis , 2003, European journal of immunology.

[27]  S. Johnston,et al.  Respiratory Epithelial Cell Expression of Vascular Cell Adhesion Molecule-1 and Its Up-regulation by Rhinovirus Infection via NF-κB and GATA Transcription Factors* , 1999, The Journal of Biological Chemistry.

[28]  G. Stark,et al.  JAKs, STATs and signal transduction in response to the interferons and other cytokines. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[29]  Jie Xu,et al.  Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond. , 2020, Advances in experimental medicine and biology.